Answers are grounded in this paper and cite their sources.
INTRODUCTION: Agent Orange (AO) exposure has been associated with increased risk of monoclonal gammopathy of undetermined significance (MGUS), the precursor of multiple myeloma, as well as certain hematologic and solid malignancies in U.S. military personnel. However, the association between AO exposure and subsequent cancers among Veterans with a prior diagnosis of MGUS has not been examined. MATERIALS AND METHODS: The source of subjects were US Veterans diagnosed with MGUS in the national Veteran Health Administration system between 1988 and 2024. A retrospective cohort analysis using multivariable Cox proportional hazards models was employed to evaluate the association between AO exposure and developing certain service-connected cancers after MGUS diagnosis, adjusting for age at MGUS diagnosis, sex, military branch, and tobacco use. Results were reported as adjusted hazard ratios (aHR) with 95% confidence intervals (CI). RESULTS: Subsequent cancers occurred in 850 out of 3,246 patients (26%) during the study period with a median follow-up of 5.2 years. AO exposure was not associated with a higher rate of cancers overall (aHR, 0.95; 95% CI, 0.79-1.15; P = .60), or specific service-connected cancers, such as plasma cell neoplasms (aHR, 1.07; 95% CI, 0.78-1.47; P = .69), respiratory cancer (aHR, 0.86; 95% CI, 0.55-1.34; P = .50), prostate cancer (aHR, 1.05; 95% CI, 0.69-1.62; P = .81), and lymphoma (aHR, 1.10; 95% CI, 0.63-1.93; P = .73). Bladder cancer and soft tissue sarcoma had insufficient counts for stable model-based estimation and are reported descriptively only. CONCLUSIONS: Prior AO exposure was not associated with an increased rate of subsequent service-connected cancers in Veterans diagnosed with MGUS over a median follow-up of 5.2 years. These findings underscore the need for improved exposure data collection within military personnel cohorts to facilitate discovery of military-specific cancer risk factors.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: